Search results
Biogen Pharmachem Industries - Closure of Trading Window
CNBC Awaaz· 4 days agoBiogen Pharmachem Industries - Closure of Trading Window
Biogen completes $1.15bn HI-Bio acquisition to expand immunology presence
Pharmaceutical Technology· 6 days agoAs Eli Lilly’s Kisunla (donanemab) enters the Alzheimer's treatment space, its leading competitor ...
Biogen Pharmachem Industries Ltd Stock Price: Biogen Pharma Share Price Today | India Infoline
India Infoline· 6 days agoBiogen Pharmachem Industries Ltd was formerly incorporated as Wellworth Overseas Limited in July, 1995. The name of the Company was changed to Sun Techno Overseas Limited ...
UniQure stock surges on data for Huntington’s gene therapy
BioPharma Dive· 10 hours agoThe biotech’s stock rose more than 60% as fresh data appeared to alleviate some investor concerns...
Daily Morning Newsletter
The Economic Times· 7 days agoHealth News: ETHealthworld.com brings latest healthcare news, views and updates. Get healthcare industry & sector news from all top sources for the...
Polpharma looks to challenge Takeda’s Entyvio in IBD
Pharmaceutical Technology· 1 day agoAnother biosimilar developed by Polpharma is Biogen’s Tysabri (natalizumab) biosimilar, Tyruko. The biosimilar is licensed to Sandoz, which bears...
FDA approves Eli Lilly’s Kisunla (donanemab) for early AD
Pharmaceutical Technology· 5 days agoKisunla is the second disease-modifying therapy (DMT) to reach the AD market in the US, providing...
Eli Lilly Alzheimer's drug approved by US FDA - ET HealthWorld | Pharma
The Economic Times· 6 days agoLondon: The U.S. Food and Drug Administration on Tuesday approved Eli Lilly's treatment for early...
New Alzheimer’s drug wins approval after FDA delay
Deseret News· 7 days agoAduhelm sparked controversy and failed commercially after it was approved against the advice of an advisory panel; Biogen has since stopped producing it....
USFDA approves Eli Lilly’s drug to treat Alzheimer’s in adults
Financial Express· 7 days agoThe United States Food and Drug Administration (USFDA) on Tuesday approved a new Alzheimer’s drug...